Clinical Data for Reimbursement
Course Description:
This course provides a strategic and detailed overview of how choosing the right clinical data can accelerate time to market. It illustrates how investing in clinical trials and the right clinical development plans early on can bridge the gap between development and marketing, increase returns on investment, and create better availability for patients.
Learning Objectives:
Upon successfully completing this course, learners will be able to:
- Demonstrate how choosing the right clinical trials is an investment worthy of time and money
- Explain how trying to save money on clinical trials actually prolongs the time to market
- Illustrate how serious clinical evidence convinces buyers
- Recognize that shortcuts do not pay off in the long run
Who Should Enroll:
Clinical, regulatory, reimbursement, and marketing managers, CEOs, and board of directors members (of start-ups) are all encouraged to enroll in this course.
Prerequisite Knowledge/Requirements:
The following material is required:
- Definition of prospective vs. retrospective, controlled vs. uncontrolled, randomized vs. non-randomized, and blinded vs. non-blinded trials